Contract packaging
- One accountable partner replaces four to six fragmented vendors
- GMP, GDP and FMD-compliant serialization for EU and US markets
- No fixed minimum batch size, clinical volumes through commercial launch
Every handoff is a compliance risk and a timeline slip
Procurement teams managing secondary pharmaceutical packaging typically coordinate a design studio, a component printer, a contract packager, a serialization vendor and a 3PL. Every handoff between them is a version control risk, an audit finding waiting to happen, and a week added to your launch timeline. When a market-specific artwork change hits, you chase five inboxes instead of one.
Ecobliss was built to collapse that chain. Design, component supply, assembly, FMD serialization, GDP warehousing and distribution happen inside one GMP-certified facility in Echt, with one project lead answering for the full scope. You get one contract, one quality agreement, one audit trail.
Serialization, controlled substances, child resistance, all in-house
FMD for the EU, DSCSA for the US, plus the country-specific variations that keep supply chain managers awake. Ecobliss runs full track and trace, aggregation and tamper evidence on manual, semi-automated and fully automated lines with outer boxing and palletization. Schedule I and Schedule II controlled substance licenses are held on site, which removes one of the hardest bottlenecks in tech transfer.
For the wallet format itself, ninety percent of our clients choose cold seal, the pressure-based sealing technique we pioneered in 1995. Need child resistance for the US and EU? Locked4Kids is our own patented, dual-certified platform, designed, tooled and assembled in the same facility.
One facility, one team, one quality agreement
Forty specialists in Echt handle your artwork briefings, your component procurement, your line qualification, your serialization reconciliation and your GDP-compliant shipment. No sub-contracted printing house. No third-party serialization service bolted on at the end. No 3PL holding your finished goods hostage during a recall.
When a regulator calls, one program manager picks up the phone with the full batch history in hand. That is what full supply chain partnership actually means.
From first clinical batch to commercial launch, without switching partners
Most CMOs refuse clinical or small launch volumes because their lines are built for scale. We run clinical trial supply, commissioning batches, launch quantities and full commercial rollout on the same equipment, with the same team, under the same quality system. The tech transfer you pay for once stays valid as volumes grow. Your artwork history, your serialization master data and your batch records live in one blockchain-protected system from phase one onward.
What the engagement looks like
Step 1. Scope and feasibility
We map your current vendor stack, your market roll-out plan and your serialization requirements. Within days you receive a scoped proposal with prototyping timeline and pricing.
Step 2. Design and prototyping
In-house design produces functional prototypes in five to ten working days. Artwork is version-controlled in our blockchain-protected document system from the first iteration.
Step 3. Qualification and first batch
IQ, OQ and PQ run in parallel with component sourcing. Cold seal, blister wallet, carton, leaflet and serialization are validated as one integrated process, not as five separate vendor qualifications.
Step 4. Commercial supply and distribution
GDP-compliant warehousing and distribution close the loop. You ship from the same site where your product was packed, under one chain of custody.
Consolidate your secondary packaging supply chain
Send us your current scope, your market footprint and your serialization requirements. Within five working days you receive a concrete proposal, a prototyping plan and a named project lead.
Contract packaging questions from supply chain managers
Do you handle primary packaging, filling blisters or vials?
No. Ecobliss is strictly secondary. We take already-formed primaries, blisters, vials, pre-filled syringes, bottles, and package them into wallets, cartons and patient-ready kits. This keeps our quality system focused and our tech transfer fast.
What is your minimum batch size?
There is no fixed minimum. We run clinical trial batches, commissioning runs, launch volumes and full commercial programs on the same lines.
Are you FMD and DSCSA ready?
Yes. Full serialization, aggregation, tamper evidence and reporting are in-house for EU FMD and US DSCSA, including country-specific variations.
Do you handle controlled substances?
Yes. Schedule I and Schedule II licenses are held on site, which typically removes months from tech transfer for controlled molecules.
How is artwork version control managed across markets?
Every artwork change runs through our blockchain-protected document management system, giving you an immutable audit trail per SKU and per market.
Can you take over a program that is already running with another packager?
Yes. Transfer projects are a core part of our work. We have received programs from fragmented supplier chains and consolidated them into single-partner scopes without supply interruption.
Where is the facility and which quality standards apply?
One facility in Echt, Netherlands. GMP-certified, GDP-compliant, FSC-certified (C194323), FMD-ready serialization.
Contact the team
Or send a message
One moment please, loading calendar...
